Background The effects that therapies for inflammatory bowel disease (IBD) have on immune
responses to SARS-CoV-2 vaccination are not yet fully known. Therefore, we sought to …

Anti tumour necrosis factor (anti-TNF) drugs increase the risk of serious respiratory infection
and impair protective immunity following pneumococcal and influenza vaccination. Here we …

Background COVID-19 vaccine-induced antibody responses are reduced in patients with
inflammatory bowel disease (IBD) taking anti-TNF or tofacitinib after two vaccine doses. We …

IgE is an ancient and conserved immunoglobulin isotype with potent immunological function.
Nevertheless, the regulation of IgE responses remains an enigma, and evidence of a role …

The skin is under constant renewal and exposure to environmental challenges. How
homeostasis is maintained alongside protective mechanisms against damage is unclear. Among …

Elevated postprandial glucose (PPG) is a significant risk factor for non-communicable
diseases globally. Currently, there is a limited understanding of how starch structures within a …

IgE is the least abundant circulating antibody class but is constitutively present in healthy
tissues bound to resident cells via its high-affinity receptor, FcεRI. The physiological role of …

In most transmissible spongiform encephalopathies prions accumulate in the lymphoreticular
system (LRS) long before they are detectable in the central nervous system. While a …

Vaccination is an effective population strategy for preventing severe COVID-19 disease and
reducing infection transmission. 1 The emergence of new variants, particularly more …

Immune checkpoint inhibitors (CPIs) are a relatively newly licenced cancer treatment, which
make a once previously untreatable disease now amenable to a potential cure. …